TIS tissue therapies limited

change in medical device classication?, page-8

  1. 492 Posts.
    Agree advisor. While the change in device classification is a short term impediment, it may debottleneck and expedite the the roll out of VG across the EU after a short 7 month period. Appreciate some holders may be perturbed right now, but by TIS management commencing preparatory work for a possible referral in August, it demonstrates prudent contingency planning.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.